Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

from JAMA Internal Medicine Author Interviews

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

Episode metadata supplied by the publisher feed · Published Oct 7, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

0:00 17:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Internal Medicine Author Interviews?

This episode is 17 minutes long.

When was this JAMA Internal Medicine Author Interviews episode published?

This episode was published on October 7, 2021.

Can I download this JAMA Internal Medicine Author Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!